Cronos Group Inc. (NASDAQ:CRON) Short Interest Update

Cronos Group Inc. (NASDAQ:CRON) was the target of a large drop in short interest in the month of October. As of October 31st, there was short interest totalling 3,900,000 shares, a drop of 20.7% from the October 15th total of 4,920,000 shares. Based on an average trading volume of 926,700 shares, the short-interest ratio is currently 4.2 days. Currently, 2.0% of the company’s shares are sold short.

Cronos Group Stock Performance

Cronos Group stock traded down $0.06 during midday trading on Friday, reaching $2.01. The stock had a trading volume of 1,238,069 shares, compared to its average volume of 1,932,468. The stock has a market capitalization of $768.42 million, a P/E ratio of -15.92 and a beta of 0.98. Cronos Group has a 1-year low of $1.85 and a 1-year high of $3.14. The firm’s fifty day simple moving average is $2.17 and its 200-day simple moving average is $2.35.

Hedge Funds Weigh In On Cronos Group

A number of hedge funds have recently bought and sold shares of the business. ClariVest Asset Management LLC increased its position in Cronos Group by 2.8% in the 2nd quarter. ClariVest Asset Management LLC now owns 273,184 shares of the company’s stock valued at $637,000 after acquiring an additional 7,362 shares during the period. Toronto Dominion Bank grew its position in shares of Cronos Group by 204.8% during the 1st quarter. Toronto Dominion Bank now owns 17,054 shares of the company’s stock valued at $45,000 after acquiring an additional 11,459 shares during the period. National Bank of Canada FI raised its stake in shares of Cronos Group by 1,094.4% in the second quarter. National Bank of Canada FI now owns 15,169 shares of the company’s stock valued at $35,000 after buying an additional 13,899 shares during the period. Cedar Wealth Management LLC raised its position in shares of Cronos Group by 65.4% in the second quarter. Cedar Wealth Management LLC now owns 37,935 shares of the company’s stock valued at $88,000 after purchasing an additional 15,000 shares during the period. Finally, Quantbot Technologies LP bought a new stake in shares of Cronos Group during the third quarter valued at about $37,000. 8.71% of the stock is owned by institutional investors.

About Cronos Group

Cronos Group Inc operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands.